Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,780 | -16,709 | -6,102 | -3,126 | N/A |
| Depreciation Amortization | 728 | 190 | 88 | 25 | N/A |
| Accounts payable and accrued liabilities | 2,682 | 810 | 281 | 103 | N/A |
| Other Working Capital | 3,140 | 2,277 | 457 | 148 | N/A |
| Other Operating Activity | 7,386 | 3,074 | -45 | -75 | 0 |
| Operating Cash Flow | $-40,844 | $-10,358 | $-5,321 | $-2,925 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,362 | -1,001 | -174 | -292 | N/A |
| Purchase Of Investment | -267,761 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 136,390 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1,400 | -102 | -10 | -27 | 0 |
| Investing Cash Flow | $-137,133 | $-1,103 | $-184 | $-319 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,000 | 944 | 500 | N/A |
| Debt Repayment | -2,600 | -400 | N/A | N/A | N/A |
| Common Stock Issued | 140,349 | -811 | N/A | 5 | N/A |
| Other Financing Activity | -24 | 123,203 | 0 | 8,930 | 0 |
| Financing Cash Flow | $137,725 | $123,992 | $944 | $9,435 | $N/A |
| Beginning Cash Position | 114,185 | 1,654 | 6,215 | 24 | N/A |
| End Cash Position | 73,933 | 114,185 | 1,654 | 6,215 | N/A |
| Net Cash Flow | $-40,252 | $112,531 | $-4,561 | $6,191 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,844 | -10,358 | -5,321 | -2,925 | N/A |
| Capital Expenditure | -4,362 | -1,001 | -174 | -292 | N/A |
| Free Cash Flow | -45,206 | -11,359 | -5,495 | -3,217 | 0 |